Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	927	200	199	633	309	-
Market Cap Growth	361.30%	0.34%	-68.61%	105.02%	-	-
Enterprise Value	708	71	37	516	292	-
Last Close Price	5.37	1.45	1.56	5.03	3.17	-
PS Ratio	-	234.71	-	-	-	-
PB Ratio	4.55	1.59	1.34	3.49	2.21	-
P/TBV Ratio	4.38	1.59	1.34	3.49	2.21	-
EV/Sales Ratio	-	83.51	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.01	0.02	0.03	0.23
Asset Turnover	-	0.01	-	-	-	-
Quick Ratio	17.72	14.28	19.54	11.54	13.59	4.66
Current Ratio	17.82	14.96	19.73	12.05	13.84	4.97
Return on Equity (ROE)	-37.82%	-36.07%	-25.74%	-24.39%	-91.30%	-115.21%
Return on Assets (ROA)	-23.47%	-23.81%	-17.66%	-14.73%	-19.00%	-42.25%
Return on Capital (ROIC)	-24.48%	-25.09%	-18.80%	-15.84%	-20.21%	-45.80%
Return on Capital Employed (ROCE)	-32.60%	-43.10%	-33.80%	-22.70%	-21.80%	-66.50%
Earnings Yield	-7.17%	-24.75%	-21.37%	-6.19%	-26.60%	-
FCF Yield	-4.91%	-22.50%	-20.44%	-5.42%	-6.98%	-
Buyback Yield / Dilution	-8.16%	-8.15%	-20.76%	-67.31%	-104.28%	-359.96%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q